Prachi Pisal, Sanket Koul, Aneeka Chatterjee

Stories by Prachi Pisal, Sanket Koul, Aneeka Chatterjee

Abbott Bets On Semaglutide Boom

Abbott Bets On Semaglutide Boom

Rediff.com   17 hours ago

Abbott will exclusively distribute and market Extensior in the country, becoming the second company to secure sole distribution rights for Novo's semaglutide portfolio in India, after Emcure Pharma.

CDSCO allows immediate lab testing of drugs to speed up approvals

CDSCO allows immediate lab testing of drugs to speed up approvals

Rediff.com   1 days ago

The Centre has allowed companies to begin lab testing immediately after filing applications instead of waiting for detailed scrutiny, in a move to expedite approvals for manufacture, or import of new drugs.

Gurugram Dethrones Mumbai As India's Luxury Housing Capital

Gurugram Dethrones Mumbai As India's Luxury Housing Capital

Rediff.com   4 days ago

Gurugram has overtaken Mumbai to become India's biggest luxury housing market in 2025, recording 24,120 crore in sales of homes priced above 10 crore.

Empty PG Seats, Missing Doctors

Empty PG Seats, Missing Doctors

Rediff.com   5 days ago

'When young doctors see limited protection, unpredictable careers and an absence of institutional support, they hesitate.'

HUL tops sustainability rankings as India Inc deepens ESG focus

HUL tops sustainability rankings as India Inc deepens ESG focus

Rediff.com   19 Feb 2026

Hindustan Unilever (HUL) has topped the Perpetual Capital Hurun India Impact 50 - 2026 list with 53.9 points (on the scale of 0-100), reflecting a strong performance across key sustainable development goals (SDGs), including climate, water, circularity, gender and biodiversity.

Indian pharma to get stronger dose of EU mkt access

Indian pharma to get stronger dose of EU mkt access

Rediff.com   5 Feb 2026

The European Union's (EU's) offer to slash tariffs on 97.5 per cent of Indian chemical exports to zero is set to give India's pharmaceutical and medical device firms preferential access to the European markets.

Realty to get indirect push from Budget proposals

Realty to get indirect push from Budget proposals

Rediff.com   3 Feb 2026

The government's Budget announcements providing tax holiday for data centres, setting up of city economic regions (CERs) and funding to improve infrastructure in Tier-II and -III cities may give an indirect boost to India's realty sector, said industry executives.

Economic Syrvey flags India's siloed city governance model

Economic Syrvey flags India's siloed city governance model

Rediff.com   31 Jan 2026

Through policy interventions, Indian cities need to be reimagined as a network of inter-connected assets and services which serve to strengthen the social contract between citizens and their cities by improving their quality of life, the Economic Survey has flagged.

Under 40 Founders Power Rs 31 Trillion

Under 40 Founders Power Rs 31 Trillion

Rediff.com   30 Jan 2026

Interestingly, with 83 per cent of entrepreneurs being first-generation founders, the list reflects India's growing spirit of entrepreneurship and leadership.

Centre mandates blue strip on antimicrobial drugs to curb overuse

Centre mandates blue strip on antimicrobial drugs to curb overuse

Rediff.com   24 Jan 2026

The Union health ministry has issued draft rules to mandate a blue vertical strip on all antimicrobial drug labels, aiming to rein in over-the-counter misuse and tackle India's growing antimicrobial resistance (AMR) problem.

Dr Reddy's profit down 14% on low Lenalidomide US sales

Dr Reddy's profit down 14% on low Lenalidomide US sales

Rediff.com   22 Jan 2026

Pharma major Dr Reddy's Laboratories (DRL) reported a 14 per cent year-on-year (Y-o-Y) drop in consolidated net profit to Rs 1,210 crore in the December quarter of FY 2025-26 (Q3FY26) on low sales of cancer drug Lenalidomide in the North American market. The firm's revenue from operations grew to Rs 8,727 crore in Q3FY26, a 4.4 per cent Y-o-Y increase from Rs 8,357 crore recorded for the same quarter last year.

NEET-PG Cutoff Cut Sparks Merit Debate

NEET-PG Cutoff Cut Sparks Merit Debate

Rediff.com   22 Jan 2026

'To fill these seats, eligibility is being diluted. We are compromising merit and producing degree holders instead of good doctors.'

Realty moves to the core of conglomerates' biz strategy

Realty moves to the core of conglomerates' biz strategy

Rediff.com   21 Jan 2026

India's leading conglomerates are stepping up investments in real estate, recasting what was once a peripheral activity into a core growth driver. Supported by strong balance sheets, established brands and access to long-term capital, major business houses including Aditya Birla, Tata, Godrej, L&T, Raymond, Wadia, Shapoorji Pallonji, Mahindra and Adani are positioning realty as a strategic pillar within their diversified portfolios.

Cheers! Kingfisher rolls out Smooth for beer aficionados

Cheers! Kingfisher rolls out Smooth for beer aficionados

Rediff.com   16 Jan 2026

The new beer's rollout has begun in Rajasthan. Under a phased expansion strategy, Karnataka is expected to follow, with more states to be added based on early response.

Ageing CBD offices emerge as developers' next growth play

Ageing CBD offices emerge as developers' next growth play

Rediff.com   13 Jan 2026

Office redevelopment is emerging as a key growth frontier for developers as India's commercial real estate market shifts towards quality, sustainability, and capital efficiency. With land parcels scarce in central business districts (CBDs) and demand for Grade A offices remaining strong, developers and investors are increasingly turning to ageing office stock in prime locations to unlock value.

Women Power India's Retail Push

Women Power India's Retail Push

Rediff.com   5 Jan 2026

'It's harder to attract women initially, but once they come in, retention is significantly higher.'

Govt Bans Sale Of Oral Nimesulide

Govt Bans Sale Of Oral Nimesulide

Rediff.com   2 Jan 2026

The Union health ministry has banned the manufacture, sale and distribution of all oral formulations containing the popular painkiller nimesulide above 100 milligrams for human use, citing health risks.

At 150k, Mumbai logs highest property registrations in 14 yrs in 2025

At 150k, Mumbai logs highest property registrations in 14 yrs in 2025

Rediff.com   1 Jan 2026

Mumbai recorded its strongest housing market performance in 14 years in 2025, with property registrations rising to 150,254, amid a sustained end-user demand and supportive supply-side ecosystem, according to Knight Frank India.

Centre Proposes Stricter Cough Syrup Rules

Centre Proposes Stricter Cough Syrup Rules

Rediff.com   1 Jan 2026

Following the death of 22 children due to consumption of contaminated cough syrups in Madhya Pradesh three months ago, the Union health ministry has proposed amendments in the country's drug rules to ensure a tougher criterion for their over-the-counter (OTC) sales in India.

Why non- NCR developers are flocking to Gurugram

Why non- NCR developers are flocking to Gurugram

Rediff.com   30 Dec 2025

Gurugram, already established as the corporate hub of Delhi-NCR, is increasingly attracting developers from outside the region, drawn by robust end-user demand, premium pricing, and emerging development opportunities.